Skip to main content
. Author manuscript; available in PMC: 2010 Aug 23.
Published in final edited form as: J Immunol. 2009 Oct 21;183(10):6313–6319. doi: 10.4049/jimmunol.0803422

Figure 4. UCP2 decreases mast cell histamine content.

Figure 4

(A) Total skin histamine of wild-type and Ucp2−/− mice quantified by ELISA. Data are normalized to the tissue weight. *P < 0.05. Graph represents the mean and individual data of 6–7 mice per genotype. (B) Representative photomicrographs of dorsal skin from wild-type and Ucp2−/− mice stained with toluidine blue. Metachromatic mast cells are also indicated by arrows. (C) Number of mast cells per mm2 in cross-section of skin. Mast cells were counted in 5 randomly chosen fields from 3 sections per mouse. Data represent the mean ± SD of 5 mice per genotype. P > 0.05. (C) Total histamine content of wild-type and Ucp2−/− BMMCs was measured spectrophotometrically and normalized to cell number. *P < 0.05 vs. wild-type (t-test). Data is the mean ± SD of three experiments. (D) Total histamine content of LAD2 cells 5 days after transduction with a control lentivirus or UCP2 overexpression lentivirus. *P < 0.05 vs. control cells. Data is the mean ± SD (n=3).

HHS Vulnerability Disclosure